PPARγ blockage did not neutralize the effect of pioglitazone on PPARγ mRNA expression in all three colon cancer cell lines (HT-29, Δ0.42; SW-480, Δ0.48; and SW-620, 0.27; P<0.05). Here, PPARG is linked to malignant colon neoplasm.